or if you experience itching, fever, blistering, mouth sores, pink eye (conjunctivitis), swelling, muscle/joint aches, yellowing of the skin or eyes, stomach pain, or tingling/numbness of the hands/feet.

Nausea, headache, also may occur.

Notify your prescriber if these problems persist or worsen.

Watch the latest videos on YouTube.com

Precautions:

Before taking this medicine, tell your prescriber if you have liver or kidney disease, or any allergies.

Any rash that develops must be reported promptly to your doctor.

This medication should be used only when clearly needed during pregnancy.

Discuss the risks and benefits with your doctor.

This drug is excreted into breast milk.

Because breast milk can transmit HIV, do not breast-feed.

Generic Name: Nevirapine

Viramune 200 mg Tablet - Prescription

Viramune 50 mg/5 ml Suspension, Oral - Prescription

nevirapine

Objective: To draw attention to the many cases of Stevens--Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) related to nevirapine detected in a multinational case--control study of SJS and TEN.
Methods: Actively detected cases and matched hospital controls were interviewed for exposure to drugs and other risk factors.
The reaction began 10--240 days after the introduction of nevirapine (median, 12 days) and all patients had received escalating doses.
In 10 patients the reaction occurred with the initial dosage.

http://www.altheal.org/pdf/nevirapine1.pdf
Because of the severity of these reactions and the long elimination half-life of nevirapine, we suggest discontinuation of the drug as soon as any eruption occurs. nevirapine, HIV infection.

nevirapine

It improves the function of the immune system, helping to prevent other infections that may occur in patients with HIV disease (increases the CD4 counts) - It may help increase appetite which helps patients to gain weight and improve their energy level.
Nevirapine is available as a 200 mg tablet and should be stored in a tightly closed container at room temperature.
Starting at a lower dose for the first 2 weeks has been shown to decrease the development of rash, a common side effect with nevirapine.
Check with your doctor immediately if you develop a rash while taking nevirapine.

http://www.cw.bc.ca/oaktree/pdf/nevirapine.pdf
In most cases the rash can be treated with anti-inflammatory medications (eg. Advil®, Naproxen®) and antihistamines (eg. Reactine®, Claritin®). nevirapine, Adults.

nevirapine

Side effects: The major side effect of nevirapine is a rash, which happened to 22% of people in studies.
If nevirapine causes a severe rash and you have to stop treatment, the company that makes the drug recommends that you DO NOT try the drug again.
Other side effects can be elevated liver function tests, fever and muscle soreness.
Reverse transcriptase is a part of HIV required to infect cells in the body and make more virus.
Nevirapine has been approved for use in combination with other anti-HIV drugs, including protease inhibitors.

http://www.aegis.com/factshts/network/simple/pdf/nevi.pdf
Nevirapine combined with indinavir (Crixivan) has been shown to have a strong anti-HIV effect, but the dose of Crixivan may need to be increased to 1,000mg every 8 hours due to a drug interaction (see below). nevirapine, Fortovase.

virapi

Severe, life-threatening, and in some cases fatal hepatotoxicity, including fulminant and cholestatic hepatitis, hepatic necrosis and hepatic failure, has been reported in patients treated with VIRAMUNE.
These have included cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, and hypersensitivity reactions characterized by rash, constitutional findings, and organ dysfunction.
Patients developing signs or symptoms of severe skin reactions or hypersensitivity reactions must discontinue VIRAMUNE as soon as possible.
The majority of these patients received 120 mg/m2/day of nevirapine for approximately 4 weeks followed by 120 mg/m2/b.i.d.

http://www.fda.gov/medwatch/SAFETY/2000/virapi.pdf
Thirty-five percent of patients treated with VIRAMUNE® experienced rash compared with 19% of patients treated in control groups of either ZDV+ddI or ZDV alone (Table 2). nevirapine, symptoms.